CFDA’s New Draft Policy Introduces the Chinese Version of Patent Linkage

Published date16 May 2017
Law FirmAllen & Overy LLP
AuthorJill Ge,David Shen,Dylan Ding
Subject MatterMedical Devices,Patents,China,Prescription Drugs,CFDA,Comment Period,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT